Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 4/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.35 |
| ▸ | FDPS | P14324 | 2/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27200268 | 0.86 | ALOX15 (0.65) | ALOX15ALDH1A1NFE2L2USP2TDP1 | |
| SCHEMBL3152826 | 0.85 | ALOX15 (0.62) | ALOX15ALDH1A1NFE2L2USP2TDP1 | |
| SCHEMBL17955365 | 0.85 | ALOX15 (0.62) | ALOX15ALDH1A1NFE2L2USP2TDP1 | |
| SCHEMBL16902070 | 0.85 | ALOX15 (0.62) | ALOX15ALDH1A1NFE2L2USP2TDP1 | |
| SCHEMBL17955363 | 0.85 | ALOX15 (0.62) | ALOX15ALDH1A1NFE2L2USP2TDP1 | |
| SCHEMBL4448320 | 0.81 | ALOX15 (0.62) | ALOX15ALDH1A1NFE2L2USP2TDP1 | |
| SCHEMBL8397532 | 0.80 | ALOX15 (0.67) | ALOX15ALDH1A1NFE2L2USP2TDP1 | |
| SCHEMBL8059226 | 0.80 | ALOX15 (0.67) | ALOX15ALDH1A1NFE2L2USP2TDP1 | |
| SCHEMBL5604473 | 0.80 | ALOX15 (0.57) | ALOX15ALDH1A1NFE2L2USP2TDP1 | |
| SCHEMBL5604557 | 0.80 | ALOX15 (0.57) | ALOX15ALDH1A1NFE2L2USP2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180360706-A1 | Delivery Particles | PROCTER & GAMBLE (US) | 2018-12-20 | — | — | US | claimed |
| US-20110268802-A1 | DELIVERY PARTICLE | THE PROCTER & GAMBLE COMPANY | 2011-11-03 | — | — | US | claimed |
| US-20240238748-A1 | CAPSULES | PROCTER & GAMBLE (US) | 2024-07-18 | — | — | US | disclosed |
| US-11904287-B2 | Capsules | THE PROCTER & GAMBLE COMPANY (US) | 2024-02-20 | — | — | US | disclosed |
| US-20230201786-A1 | Methods of Making Capsules | PROCTER & GAMBLE (US) | 2023-06-29 | — | — | US | disclosed |
| US-11628413-B2 | Methods of making capsules | THE PROCTER & GAMBLE COMPANY (US) | 2023-04-18 | — | — | US | disclosed |
| US-20220409497-A1 | DELIVERY PARTICLE | PROCTER & GAMBLE (US) | 2022-12-29 | — | — | US | disclosed |
| US-20220258118-A1 | Capsules | PROCTER & GAMBLE (US) | 2022-08-18 | — | — | US | disclosed |
| EP-3956427-A1 | CAPSULES | The Procter & Gamble Company (US) | 2022-02-23 | — | — | EP | disclosed |
| EP-3955890-A1 | CAPSULES | The Procter & Gamble Company (US) | 2022-02-23 | — | — | EP | disclosed |
| EP-3956054-A1 | METHODS OF MAKING CAPSULES | The Procter & Gamble Company (US) | 2022-02-23 | — | — | EP | disclosed |
| EP-2563507-A2 | DELIVERY PARTICLES | The Procter & Gamble Company (US) | 2013-03-06 | — | — | EP | disclosed |
| EP-2563508-A2 | DELIVERY PARTICLE | The Procter & Gamble Company (US) | 2013-03-06 | — | — | EP | disclosed |
| US-20110269657-A1 | DELIVERY PARTICLES | THE PROCTER & GAMBLE COMPANY | 2011-11-03 | — | — | US | disclosed |
| US-20110268778-A1 | DELIVERY PARTICLES | THE PROCTER & GAMBLE COMPANY | 2011-11-03 | — | — | US | disclosed |
| US-20110269658-A1 | DELIVERY PARTICLES | THE PROCTER & GAMBLE COMPANY | 2011-11-03 | — | — | US | disclosed |
| US-20110268802-A1 | DELIVERY PARTICLE | THE PROCTER & GAMBLE COMPANY | 2011-11-03 | — | — | US | disclosed |
| WO-2010084480-A2 | DELIVERY PARTICLES | THE PROCTER & GAMBLE COMPANY (US) | 2010-07-29 | — | — | WO | disclosed |
| WO-2010079468-A2 | DELIVERY PARTICLE | THE PROCTER & GAMBLE COMPANY (US) | 2010-07-15 | — | — | WO | disclosed |
| WO-2010079467-A2 | DELIVERY PARTICLES | THE PROCTER & GAMBLE COMPANY (US) | 2010-07-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220409497-A1 | DELIVERY PARTICLE | LIPA, CHMP4B, SLC46A1 | ALOX15 1141/4885ALDH1A1 1476/4885NFE2L2 1604/4885 |
| US-20180360706-A1 | Delivery Particles | LIPA, CHMP4B, ABCB4 | ALOX15 909/4885ALDH1A1 1320/4885NFE2L2 1532/4885 |
| US-11628413-B2 | Methods of making capsules | FUT6, FUT5, LIPA | ALOX15 288/4885ALDH1A1 1603/4885NFE2L2 1041/4885 |
| US-20230201786-A1 | Methods of Making Capsules | FUT6, FUT5, LIPA | ALOX15 288/4885ALDH1A1 1603/4885NFE2L2 1041/4885 |
| US-20110268802-A1 | DELIVERY PARTICLE | LIPA, CHMP4B, SLC46A1 | ALOX15 1141/4885ALDH1A1 1476/4885NFE2L2 1604/4885 |
| US-20110268778-A1 | DELIVERY PARTICLES | LIPA, CHMP4B, ABCB4 | ALOX15 909/4885ALDH1A1 1320/4885NFE2L2 1532/4885 |
| US-20110269658-A1 | DELIVERY PARTICLES | LIPA, CHMP4B, ABCB4 | ALOX15 909/4885ALDH1A1 1320/4885NFE2L2 1532/4885 |
| US-20110269657-A1 | DELIVERY PARTICLES | LIPA, CHMP4B, ABCB4 | ALOX15 909/4885ALDH1A1 1320/4885NFE2L2 1532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.